Seminarreihe
Vortragsreihe "Seminars in Lipid Signalling"
SFB 1039 Krankheitsrelevante Signaltransduktion durch Fettsäurederivate und Sphingolipide
Ort: Haus 74, Seminarraum 4. OG, Raum 4.107 Universitätsklinikum Frankfurt, Goethe-Universität
| Datum | Sprecher | Vortragstitel |
|---|---|---|
| 29.04.2025 13 Uhr |
Prof. Charles Frevert Department of Comparative Medicine Division of Pulmonary, Critical Care, and Sleep Medicine University of Washington, Seattle, USA |
Versican-Hyaluronan Matrices: Key Players in the Innate Immune Response to Influenza A Virus |
| 18.09.2024 12 Uhr |
Holger Stark, PhD Univ.-Prof. Dr. Dr. h.c Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-Universitaet Duesseldorf |
New pharmacological tools to modulate key elements in sphingolipide cascade |
| 18.09.2024 12 Uhr |
Dr. Gergely Gyimesi Department for BioMedical Research, University of Bern, Switzerland |
Structural basis of lipid recognition in solute carrier (SLC) lipid transporters |
| 07.03.2024 16 Uhr |
PD Dr. Florian Freudenberg Department of Psychiatry, Psychosomatics and Psychotherapy, Frankfurt |
Molecular Crossroads: Neuroinflammation, Lipid Signaling, and Their Impact on Mental Disorders |
| 05.03.2024 13 Uhr |
Prof. Stephan von Gunten Institut für Pharmakologie, Universität Bern, Schweiz |
The role of glycolipids and -proteins in inflammation and tumor immunology |
| 08.04.2020 15 Uhr |
Jerome Dejardin, PhD Institute of Human Genetics, University of Montpellier |
Locus-specific chromatin isolation |
| 04.03.2020 16 Uhr |
Patrick Niekamp Universität Osnabrück |
Sphingomyelin biosynthesis is essential for phagocytic signaling during mycobacteria host cell entry |
| 18.02.2020 12 Uhr |
Dr. Michaela Schedel National Jewish Health, University Duisburg-Essen |
Molecular and functional mechanisms contribute to the development of respiratory diseases |
| 05.02.2020 16 Uhr |
Prof. Dr. Dr. rer. nat. Dieter Lütjohann Universitätsklinikum Bonn |
Niemann-Pick disease type C - pathophysiology, diagnosis and therapy in human |
| 17.12.2019 12 Uhr |
Prof. Dr. med. Erich Gulbins Universität Duisburg-Essen |
Sphingolipids in pulmonary infections |
| 12.11.2019 12 Uhr |
Dr. Miroslav Machala Head, Department of Chemistry and Toxicology Veterinary Research Institute, Brno, Czech Republic |
Searching for candidates for novel lipidomic biomarkers in colon cancer-derived tissue samples |
| 24.09.2019 12 Uhr |
Prof. David Bishop-Bailey University of London |
A role for CYP450 derived lipids in inflammatory resolution? |
| 27.08.2019 12 Uhr |
Prof. Dr. Jürgen Seibel Universität Würzburg |
Exploring new frontiers of carbohydrate and lipid science: From chemical design to biological function |
| 25.06.2019 12 Uhr |
Jan Schlegel Universität Würzburg |
Super-resolution microscopy of sphingolipids in health and disease |
| 18.06.2019 12 Uhr |
Joost Holthuis, PhD Professor of Molecular Cell Biology University of Osnabrueck |
Dissecting protein-lipid crosstalk in life-death decision making with photo-actuated lipid probes |
| 14.05.2019 12 Uhr |
Prof. Ralph Witzgall University of Regensburg Institute for Molecular and Cellular Anatomy |
The ion-conducting properties of polycystin-2, a TRP channel mutated in autosomal-dominant polycystic kidney disease, determine the width and integrity of tubular structures in the kidney |
| 12.02.2019 12:30 Uhr |
Dr. Chris Thomas School of Pharmacy and Pharmaceutical Sciences Cardiff University |
Detection and characterisation of novel oxidised lipids from lipoxygenase enzymes |
| 11.12.2018 12 Uhr |
Professor Charles W. Frevert DVM, ScD University of Washington at South Lake Union |
Versican: A Key Immunomodulatory Molecule of the Innate Immune Response to Lung Infection |
| 04.12.2018 12 Uhr |
Dr. Volker Brinkmann Director & Distinguished Scientist a. D. Novartis Institutes for BioMedical Research Basel, Schweiz |
On the Molecular Medicine of Sphingolipids: Discovery and mechanisms of the Multiple Sclerosis Drug Fingolimod (Gilenya®) |
| 11.09.2018 12 Uhr |
Prof. Dr. Claudia Pellizas National University of Cordoba, Argentina |
Impact of Thyroid Hormones at the initiation of the immune response. Role in antitumor immunity |
| 07.08.2018 12 Uhr |
Professor Jun Zhu Icahn School of Medicine at Mount Sinai |
Integrative Network Analysis of Lipid Biosynthesis and Cell Response to Lipids |
| 10.07.2018 12 Uhr |
Dr. Norbert Tennagels Sanofi-Aventis Deutschland GmbH Biochemistry |
Revisiting Ceramide Signaling for Insulin Resistance Targeting |
| 26.06.2018 12 Uhr |
Prof. Dr. Dagmar Wachten University of Bonn, Institute of Innate Immunity |
Cellular functions of GlcCer and GBA2 |
| 12.06.2018 12 Uhr |
Dr. Kirstin Schilling INNOVECTIS GmbH |
Intellectual Property at University – How to patent and license research results |
| 29.05.2018 12 Uhr |
Prof. Dr. Peter Mattjus Abo Academy University, Turku, Finland |
Glycosphingolipids and their transfer proteins |
| 08.05.2018 12 Uhr |
Prof. Dr. Thorsten Hornemann Institute for Clinical Chemistry University Hospital Zurich |
No Brain No Pain - Headless Sphingolipids and Neuropathies |
| 02.05.2018 17 Uhr |
Prof. Dr. Hermann Eibel University Medical Center Freiburg Center for Chronic Immunodeficiency |
Mutations in CTLA-4 and JAK3 correlate with immunodysregulation |
| 26.04.2018 18 Uhr |
Prof. Dr. Hartmut Kühn Charité - Universitätsmedizin Berlin |
The patho-physiological role of leukotrienes and other eicosanoids in inflammatory diseases |
| 17.04.2018 12 Uhr |
Univ.-Prof. Dr. med. Mario Schiffer Medizinische Hochschule Hannover Klinik für Nieren- und Hochdruckerkrankungen |
The cytoskeleton of the podocyte: a translational treatment target option? |
| 06.02.2018 12 Uhr |
Prof. Dr. Dr. h. c. Dontscho Kerjaschki Medical University of Vienna |
The sentinel lymph node: a hub for metastatic tumor cell dissemination |
| 10.01.2018 12 Uhr |
Dr. rer. nat. Simone Reichelt-Wurm Universitätsklinik Regensburg |
Long non-coding RNAs in diabetic nephropathy |